New CPT Codes

06/25/2020
CPT Codes Description
J0129 Injection, abatacept, 10 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
J0178 Injection, aflibercept, 1 mg
J0179 Injection, brolucizumab-dbll, 1 mg
J0180 Injection, agalsidase beta, 1 mg
J0185 Injection, aprepitant, 1 mg
J0202 Injection, alemtuzumab, 1 mg
J0221 Injection, alglucosidase alfa, (Lumizyme), 10 mg
J0222 Injection, patisiran, 0.1 mg 
J0256 Injection, alpha 1-proteinase inhibitor (human), not otherwise specified, 10 mg
J0257 Injection, alpha 1 proteinase inhibitor (human), (GLASSIA), 10 mg
J0364 Injection, apomorphine hcl, 1 mg
J0485 Injection, belatacept, 1 mg
J0490 Injection, belimumab, 10 mg
J0517 Injection, benralizumab, 1 mg
J0565 Injection, bezlotoxumab, 10 mg
J0567 Injection, cerliponase alfa, 1 mg
J0570 Buprenorphine implant, 74.2 mg
J0584 Injection, burosumab-twza 1 mg
J0585 Injection, onabotulinumtoxinA, 1 unit
J0586 Injection, abobotulinumtoxinA, 5 units
J0587 Injection, rimabotulinumtoxinB, 100 units
J0588 Injection, incobotulinumtoxinA, 1 unit
J0593 Injection, lanadelumab-flyo, 1 mg (code may be used for Medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
J0596 Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
J0597 Injection, C-1 esterase inhibitor (human), Berinert, 10 units
J0598 Injection, C-1 esterase inhibitor (human), Cinryze, 10 units
J0599 Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
J0606 Injection, etelcalcetide, 0.1 mg
J0638 Injection, canakinumab, 1 mg
J0641 Injection, levoleucovorin, 0.5 mg
J0642 Injection, levoleucovorin (Khapzory), 0.5 mg
J0717 Injection, certolizumab pegol, 1 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0775 Injection, collagenase, clostridium histolyticum, 0.01 mg
J0800 Injection, corticotropin, up to 40 units
J0850 Injection, cytomegalovirus immune globulin intravenous (human), per vial
J0881 Injection, darbepoetin alfa, 1 mcg (non-ESRD use)
J0885 Injection, epoetin alfa, (for non-ESRD use), 1000 units
J0894 Injection, decitabine, 1 mg
J0897 Injection, denosumab, 1 mg
J1095 Injection, dexamethasone 9%, intraocular, 1 mcg
J1096 Dexamethasone, lacrimal ophthalmic insert, 0.1 mg 
J1290 Injection, ecallantide, 1 mg
J1300 Injection, eculizumab, 10 mg
J1301 Injection, edaravone, 1 mg
J1303 Injection, ravulizumab-cwvz, 10 mg
J1322 Injection, elosulfase alfa, 1 mg
J1325 Injection, epoprostenol, 0.5 mg
J1428 Injection, eteplirsen, 10 mg
J1442 Injection, filgrastim (G-CSF), excludes biosimilars, 1 microgram
J1447 Injection, tbo-filgrastim, 1 mcg
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
J1458 Injection, galsulfase, 1 mg
J1459 Injection, immune globulin (Privigen), intravenous, nonlyophilized (e.g., liquid), 500 mg
J1555 Injection, immune globulin (cuvitru), 100 mg
J1556 Injection, immune globulin (Bivigam), 500 mg
J1557 Injection, immune globulin, (Gammaplex), intravenous, nonlyophilized (e.g., liquid), 500 mg
J1559 Injection, immune globulin (Hizentra), 100 mg
J1561 Injection, immune globulin, (Gamunex/Gamunex-C/Gammaked), nonlyophilized (e.g., liquid), 500 mg
J1566 Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
J1568 Injection, immune globulin, (Octagam), intravenous, nonlyophilized (e.g., liquid), 500 mg
J1569 Injection, immune globulin, (Gammagard liquid), nonlyophilized, (e.g., liquid), 500 mg
J1571 Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
J1572 Injection, immune globulin, (Flebogamma/Flebogamma Dif), intravenous, nonlyophilized (e.g., liquid), 500 mg
J1573 Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
J1575 Injection, immune globulin/hyaluronidase, 100 mg immuneglobulin
J1599 Injection, immune globulin, intravenous, non-lyophilized (e.g. liquid), not otherwise specified, 500 mg
J1602 Injection, golimumab, 1 mg, for intravenous use
J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg
J1729 Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
J1740 Injection, ibandronate sodium, 1 mg
J1743 Injection, idursulfase, 1 mg
J1744 Injection, icatibant, 1mg
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J1746 Injection, ibalizumab-uiyk, 10 mg
J1786 Injection, imiglucerase, 10 units
J1833 Injection, isavuconazonium, 1 mg
J1930 Injection, lanreotide, 1 mg
J1931 Injection, laronidase, 0.1 mg
J2062 Loxapine for inhalation, 1 mg
J2182 Injection, mepolizumab, 1 mg
J2323 Injection, natalizumab, 1 mg
J2326 Injection, nusinersen, 0.1 mg
J2350 Injection, ocrelizumab, 1 mg
J2353 Injection, octreotide, depot form for intramuscular injection, 1 mg
J2357 Injection, omalizumab, 5 mg
J2469 Injection, palonosetron HCl, 25 mcg
J2502 Injection, pasireotide long acting, 1 mg
J2503 Injection, pegaptanib sodium, 0.3 mg
J2505 Injection, pegfilgrastim, 6 mg
J2507 Injection, Pegloticase, 1 mg
J2562 Injection, plerixafor, 1 mg
J2724 Injection, protein C concentrate, intravenous, human, 10 IU
J2778 Injection, ranibizumab, 0.1 mg
J2786 Injection, reslizumab, 1 mg
J2793 Injection, rilonacept, 1 mg
J2796 Injection, romiplostim, 10 mcg
J2797 Injection, rolapitant, 0.5 mg
J2820 Injection, sargramostim (GM-CSF), 50 mcg
J2840 Injection, sebelipase alfa, 1 mg
J2860 Injection, siltuximab, 10 mg
J3060 Injection, taliglucerase alfa, 10 units
J3111 Injection, romosozumab-aqqg, 1 mg
J3145 Injection, testosterone undecanoate, 1 mg
J3240 Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
J3245 Injection, tildrakizumab, 1 mg
J3262 Injection, tocilizumab, 1 mg
J3285 Injection, treprostinil, 1 mg
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
J3316 Injection, triptorelin, extended-release, 3.75 mg
J3358 Ustekinumab, for intravenous injection, 1 mg
J3380 Injection, vedolizumab, 1 mg
J3385 Injection, velaglucerase alfa, 100 units
J3397 Injection, vestronidase alfa-vjbk, 1 mg
J3398 Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
J3489 Injection, zoledronic acid, 1 mg
J3490 Unclassified drugs
J3590 Unclassified biologics
J7170 Injection, emicizumab-kxwh, 0.5 mg
J7175 Injection, factor x, (human), 1 i.u. (New Code: 01/01/2017)
J7178 Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
J7179 Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco (New Code: 01/01/2017)
J7180 Injection, factor XIII (antihemophilic factor, human), 1 IU
J7181 Injection, factor XIII A-subunit, (recombinant), per IU
J7182 Injection, factor VIII, (antihemophilic factor, recombinant), (NovoEight), per IU
J7183 Injection, von Willebrand factor complex (human), Wilate, 1 IU vWF:RCo
J7185 Injection, factor VIII (antihemophilic factor, recombinant) (XYNTHA), per IU
J7186 Injection, antihemophilic factor VIII/von Willebrand factor complex (human), per factor VIII i.u.
J7187 Injection, von Willebrand factor complex (Humate-P), per IU VWF:RCO
J7188 Injection, factor VIII (antihemophilic factor, recombinant), per IU
J7189 Factor VIIa (antihemophilic factor, recombinant), per 1 mcg
J7190 Factor VIII (antihemophilic factor, human) per IU
J7192 Factor VIII (antihemophilic factor, recombinant) per IU, not otherwise specified
J7193 Factor IX (antihemophilic factor, purified, nonrecombinant) per IU
J7194 Factor IX complex, per IU
J7195 Injection, factor IX (antihemophilic factor, recombinant) per IU, not otherwise specified
J7198 Antiinhibitor, per IU
J7199 Hemophilia clotting factor, not otherwise classified
J7200 Injection, factor IX, (antihemophilic factor, recombinant), Rixubis, per IU
J7201 Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. (Revised Code: 01/01/2017)
J7202 Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. (New Code: 01/01/2017)
J7203 Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
J7205 Injection, factor VIII Fc fusion protein (recombinant), per IU
J7207 Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. (New Code: 01/01/2017)
J7208 Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
J7209 Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. (New Code: 01/01/2017)
J7210 Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
J7211 Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
J7311 Fluocinolone acetonide, intravitreal implant
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg
J7313 Injection, fluocinolone acetonide, intravitreal implant, 0.01 mg
J7314 Injection, fluocinolone acetonide, intravitreal implant (Yutiq), 0.01 mg
J7316 Injection, ocriplasmin, 0.125 mg
J7318 Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
J7320 Hyaluronan or derivative, GenVisc 850, for intra-articular injection, 1 mg
J7321 Hyaluronan or derivative, Hyalgan or Supartz, for intra-articular injection, per dose
J7322 Hyaluronan or derivative, Hymovis, for intra-articular injection, 1 mg
J7323 Hyaluronan or derivative, Euflexxa, for intra-articular injection, per dose
J7324 Hyaluronan or derivative, Orthovisc, for intra-articular injection, per dose
J7325 Hyaluronan or derivative, Synvisc or Synvisc-One, for intra-articular injection, 1 mg
J7326 Hyaluronan or derivative, Gel-One, for intra-articular injection, per dose
J7327 Hyaluronan or derivative, Monovisc, for intra-articular injection, per dose
J7328 Hyaluronan or derivative, Gel-Syn, for intra-articular injection, 0.1 mg
J7329 Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
J7331 Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
J7332 Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
J7336 Capsaicin 8% patch, per square centimeter
J7686 Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
J9015 Injection, aldesleukin, per single use vial
J9022 Injection, atezolizumab, 10 mg
J9023 Injection, avelumab, 10 mg
J9025 Injection, azacitidine, 1 mg
J9027 Injection, clofarabine, 1 mg
J9033 Injection, bendamustine hcl (treanda), 1 mg
J9034 Injection, bendamustine hcl (bendeka), 1 mg
J9035 Injection, bevacizumab, 10 mg " to "Injection, bevacizumab, (Avastin) 10 mg (Cancer indications only; ophthalmologic injections do not require PA. Submit under J3490 with NDC
J9036 Injection, bendamustine hydrochloride, (Belrapzo), 1 mg
J9039 Injection, blinatumomab, 1 microgram
J9041 Injection, bortezomib (Velcade), 0.1 mg
J9042 Injection, brentuximab vedotin, 1 mg
J9043 Injection, cabazitaxel, 1 mg
J9044 Injection, bortezomib, not otherwise specified, 0.1 mg
J9047 Injection, Carfilzomib, 1 mg
J9055 Injection, cetuximab, 10 mg
J9057 Injection, copanlisib, 1 mg
J9118 Injection, calaspargase pegol-mknl, 10 units
J9119 Injection, cemiplimab-rwlc, 1 mg 
J9145 Injection, daratumumab, 10 mg
J9153 Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
J9173 Injection, durvalumab, 10 mg
J9176 Injection, elotuzumab, 1 mg
J9179 Injection, eribulin mesylate, 0.1 mg
J9199 Injection, gemcitabine HCl (Infugem), 200 mg
J9203 Injection, gemtuzumab ozogamicin, 0.1 mg
J9204 Injection, mogamulizumab-kpkc, 1 mg 
J9205 Injection, irinotecan liposome, 1 mg
J9207 Injection, ixabepilone, 1 mg
J9210 Injection, emapalumab-lzsg, 1 mg  
J9219 Leuprolide acetate implant, 65 mg
J9225 Histrelin implant (Vantas), 50 mg
J9226 Histrelin implant (supprelin la), 50 mg
J9228 Injection, ipilimumab, 1 mg
J9229 Injection, inotuzumab ozogamicin, 0.1 mg
J9262 Injection, omacetaxine mepesuccinate, 0.01 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9264 Injection, paclitaxel protein-bound particles, 1 mg
J9269 Injection, tagraxofusp-erzs, 10 micrograms
J9271 Injection, pembrolizumab, 1 mg
J9285 Injection, olaratumab, 10 mg
J9295 Injection, necitumumab, 1 mg
J9299 Injection, nivolumab, 1 mg
J9301 Injection, obinutuzumab, 10 mg
J9302 Injection, ofatumumab, 10 mg
J9303 Injection, panitumumab, 10 mg
J9305 Injection, pemetrexed, 10 mg
J9306 Injection, pertuzumab, 1 mg
J9307 Injection, pralatrexate, 1 mg
J9308 Injection, ramucirumab, 5 mg
J9309 Injection, polatuzumab vedotin-piiq, 1 mg
J9311 Injection, rituximab 10 mg and hyaluronidase
J9312 Injection, rituximab, 10 mg
J9313 Injection, moxetumomab pasudotox-tdfk, 0.01 mg
J9315 Injection, romidepsin, 1 mg
J9325 Injection, talimogene laherparepvec, per 1 million plaque forming units
J9328 Injection, temozolomide, 1 mg
J9330 Injection, temsirolimus, 1 mg
J9340 Injection, thiotepa, 15 mg
J9352 Injection, trabectedin, 0.1 mg
J9354 Injection, ado-trastuzumab emtansine, 1 mg
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg
J9356 Injection, trastuzumab, 10 mg and Hyaluronidase-oysk
J9371 Injection, vincristine sulfate liposome, 1 mg; 1 mg = 1 billable unit
J9400 Injection, ziv-aflibercept, 1 mg
Q2041 Axicabtagene Ciloleucel, up to 200 million autologous Anti-CD19 CAR T Cells, including leukapheresis and dose preparation procedures, per infusion
Q2042 Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Q2043 Sipuleucel-T, minimum of 50 million autologous cd54+ cells activated with PAP-GM-CSF, including leukapheresis and all other preparatory procedures, per infusion
Q2049 Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
Q2050 Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
Q4074 Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
Q5103 Injection, infliximab-dyyb, biosimilar, (Inflectra), 10 mg
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
Q5106 Injection, epoetin alfa, biosimilar, (Retacrit) (for non-ESRD use), 1000 units
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
Q5108 Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
Q5111 Injection, pegfilgrastim-cbqv, biosimilar, (Udenyca), 0.5 mg
Q5112 Injection, trastuzumab-dttb, biosimilar, (Ontruzant), 10 mg
Q5113 Injection, trastuzumab-pkrb, biosimilar, (Herzuma), 10 mg 
Q5114 Injection, Trastuzumab-dkst, biosimilar, (Ogivri), 10 mg
Q5115 Injection, rituximab-abbs, biosimilar, 10 mg
Q5116 Injection, trastuzumab-qyyp, biosimilar, (Trazimera), 10 mg
Q5117 Injection, trastuzumab-anns, biosimilar, (Kanjinti), 10 mg
Q5118 Injection, bevacizumab-bvcr, biosimilar, (Zirabev), 10 mg
Our Call Center is currently experiencing extremely high volume and longer wait times. For questions related to COVID-19, visit our COVID-19 FAQs